Table 5 Comparison of the literatures for radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombosis
Reference | N | Techniques | Fraction size (Gy) | Total dose (Gy) | Response (%) | Median survival (months) |
|---|---|---|---|---|---|---|
Toya [10] | 38 | 3D-CRT | 1.8–4 | 40 (range, 17.5–50.4) | CR = 15.8 | 9.6 |
PR = 28.9 | ||||||
Kim [11] | 59 | 3D-CRT | 2–3 | 30–54 | CR = 6.8 | Responder: 10.7 |
PR = 39.0 | Non-responder: 5.3 | |||||
McIntosh [14] | 20 | Helical Tomotherapy | 2.5 | 50 | PR = 6.2 | 9.6 |
SD = 87.5 | ||||||
Choi [15] | 9 | Cyberknife | 10–12 | 30–36 | CR = 11.1 | 8 |
PR = 33.3 | ||||||
Current study | 35 | Helical Tomotherapy | 4.5–6 | 50 (range, 45–60) | CR = 14.3 | 12.9 |
PR = 28.6 | Responder 13.9 | |||||
Non-responder 6.9 |